Annual Non Current Assets
$987.00 K
-$1.62 M-62.10%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual long term assets is $987.00 thousand, with the most recent change of -$1.62 million (-62.10%) on December 31, 2023.
- During the last 3 years, EIGR annual non current assets has fallen by -$4.80 million (-82.95%).
- EIGR annual non current assets is now -95.72% below its all-time high of $23.04 million, reached on December 31, 2021.
Performance
EIGR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$987.00 K
-$43.00 K-4.17%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly long term assets is $987.00 thousand, with the most recent change of -$43.00 thousand (-4.17%) on December 31, 2023.
- Over the past year, EIGR quarterly non current assets has dropped by -$1.62 million (-62.10%).
- EIGR quarterly non current assets is now -97.60% below its all-time high of $41.19 million, reached on September 30, 2021.
Performance
EIGR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
EIGR Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -62.1% | -62.1% |
3 y3 years | -83.0% | -83.0% |
5 y5 years | +63.7% | +63.7% |
EIGR Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -95.7% | at low | -95.7% | at low |
5 y | 5-year | -95.7% | at low | -97.6% | at low |
alltime | all time | -95.7% | +9770.0% | -97.6% | +9770.0% |
Eiger BioPharmaceuticals Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $37.84 M(-67.8%) | $987.00 K(-4.2%) |
Sep 2023 | - | $1.03 M(-45.0%) |
Jun 2023 | - | $1.87 M(-19.1%) |
Mar 2023 | - | $2.32 M(-11.0%) |
Dec 2022 | $117.53 M(+13.7%) | $2.60 M(+79.0%) |
Sep 2022 | - | $1.46 M(-75.7%) |
Jun 2022 | - | $5.99 M(+0.3%) |
Mar 2022 | - | $5.97 M(-74.1%) |
Dec 2021 | $103.36 M(-25.0%) | $23.04 M(-44.1%) |
Sep 2021 | - | $41.19 M(+8.3%) |
Jun 2021 | - | $38.03 M(+575.7%) |
Mar 2021 | - | $5.63 M(-2.7%) |
Dec 2020 | $137.81 M(+37.3%) | $5.79 M(+0.6%) |
Sep 2020 | - | $5.75 M(-1.2%) |
Jun 2020 | - | $5.82 M(-2.3%) |
Mar 2020 | - | $5.96 M(+25.3%) |
Dec 2019 | $100.38 M(-1.4%) | $4.75 M(-14.9%) |
Sep 2019 | - | $5.58 M(+22.5%) |
Jun 2019 | - | $4.56 M(-3.5%) |
Mar 2019 | - | $4.72 M(+683.1%) |
Dec 2018 | $101.84 M | $603.00 K(+5.1%) |
Sep 2018 | - | $574.00 K(+59.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2018 | - | $361.00 K(+1.1%) |
Mar 2018 | - | $357.00 K(-8.7%) |
Dec 2017 | $42.49 M(-29.8%) | $391.00 K(+150.6%) |
Sep 2017 | - | $156.00 K(-14.3%) |
Jun 2017 | - | $182.00 K(-15.0%) |
Mar 2017 | - | $214.00 K(-2.3%) |
Dec 2016 | $60.52 M(+78.6%) | $219.00 K(-0.9%) |
Sep 2016 | - | $221.00 K(+4.2%) |
Jun 2016 | - | $212.00 K(+5.5%) |
Mar 2016 | - | $201.00 K(+1910.0%) |
Dec 2015 | $33.88 M(-61.5%) | $10.00 K(-93.0%) |
Sep 2015 | - | $143.00 K(-80.8%) |
Jun 2015 | - | $743.00 K(-24.0%) |
Mar 2015 | - | $978.00 K(-4.8%) |
Dec 2014 | $88.08 M(+374.8%) | $1.03 M(+14.6%) |
Sep 2014 | - | $896.00 K(+73.6%) |
Jun 2014 | - | $516.00 K(+41.8%) |
Mar 2014 | - | $364.00 K(-86.0%) |
Dec 2013 | $18.55 M(-43.7%) | $2.60 M(+118.5%) |
Sep 2013 | - | $1.19 M(+1035.2%) |
Jun 2013 | - | $105.00 K |
Dec 2012 | $32.94 M(+6513.9%) | - |
Dec 2011 | $498.00 K | - |
FAQ
- What is Eiger BioPharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual non current assets year-on-year change?
- What is Eiger BioPharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly non current assets year-on-year change?
What is Eiger BioPharmaceuticals annual long term assets?
The current annual non current assets of EIGR is $987.00 K
What is the all time high annual non current assets for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual long term assets is $23.04 M
What is Eiger BioPharmaceuticals annual non current assets year-on-year change?
Over the past year, EIGR annual long term assets has changed by -$1.62 M (-62.10%)
What is Eiger BioPharmaceuticals quarterly long term assets?
The current quarterly non current assets of EIGR is $987.00 K
What is the all time high quarterly non current assets for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly long term assets is $41.19 M
What is Eiger BioPharmaceuticals quarterly non current assets year-on-year change?
Over the past year, EIGR quarterly long term assets has changed by -$1.62 M (-62.10%)